Back to Agenda
Precision Medicine: Gene-Editing, Advance Therapies and Personalised Medicine
Session Chair(s)
Klaus Cichutek, PhD
Director
Paul-Ehrlich-Institut, Germany
Precision medicine is the present and future of tailored therapies. This session covers 3 important aspects of precision medicine: 1) Precision in genome editing using e.g. Crisp/Cas technology allows us to modify cells and use them to treat cancer, infectious disease and hematological conditions. 2) With precision medicine, treatment choice and benefit-risk assessment will have to rely on new and more individualised methods, such as generalised pairwise comparisons of patient outcomes. 3) Genomics on a population scale may be used to identify individual disease risks and suitability of preventive measures, even before the onset of disease.
Learning Objective : Provide an overview of the current gene editing landscape Review the key differences among different available technologies Explain opportunities to treat human diseases Discuss the regulatory and ethical considerations
Speaker(s)
Overview of Current Gene Editing Landscape
Tatiana Anna Reimer, PhD
Bayer AG, Germany
Director Regulatory Affairs Cell and Gene Therapy
The Future of Personalised Medicine – Exploring the Successes and Challenges
Kristiina James
Abbvie Ltd, United Kingdom
Regulatory Product Lead, MEAR
From Precision to Personalised Medicine: Generalised Pairwise Comparisons as a Tool to Individualise Treatment Choices
Everardo Saad, MD
IDDI, Belgium
Medical Director
Have an account?